These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27325646)

  • 1. Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines.
    Guo S; Qian W; Cai J; Zhang L; Wery JP; Li QX
    Cancer Res; 2016 Aug; 76(16):4619-26. PubMed ID: 27325646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
    Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
    Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
    Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
    Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
    J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma.
    Wang W; Iyer NG; Tay HT; Wu Y; Lim TK; Zheng L; Song IC; Kwoh CK; Huynh H; Tan PO; Chow PK
    BMC Cancer; 2015 Oct; 15():828. PubMed ID: 26520397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
    Paez-Ribes M; Man S; Xu P; Kerbel RS
    PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.
    Lawrence MG; Pook DW; Wang H; Porter LH; Frydenberg M; Kourambas J; Appu S; Poole C; Beardsley EK; Ryan A; Norden S; Papargiris MM; Risbridger GP; Taylor RA
    Prostate; 2015 Sep; 75(13):1475-83. PubMed ID: 26177841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.
    Li Y; Kang K; Krahn JM; Croutwater N; Lee K; Umbach DM; Li L
    BMC Genomics; 2017 Jul; 18(1):508. PubMed ID: 28673244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
    Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
    Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse.
    du Manoir S; Orsetti B; Bras-Gonçalves R; Nguyen TT; Lasorsa L; Boissière F; Massemin B; Colombo PE; Bibeau F; Jacot W; Theillet C
    Mol Oncol; 2014 Mar; 8(2):431-43. PubMed ID: 24394560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond genomics: critical evaluation of cell line utility for ovarian cancer research.
    Elias KM; Emori MM; Papp E; MacDuffie E; Konecny GE; Velculescu VE; Drapkin R
    Gynecol Oncol; 2015 Oct; 139(1):97-103. PubMed ID: 26321251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract.
    Damhofer H; Ebbing EA; Steins A; Welling L; Tol JA; Krishnadath KK; van Leusden T; van de Vijver MJ; Besselink MG; Busch OR; van Berge Henegouwen MI; van Delden O; Meijer SL; Dijk F; Medema JP; van Laarhoven HW; Bijlsma MF
    J Transl Med; 2015 Apr; 13():115. PubMed ID: 25884700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies.
    Hanna C; Kwok L; Finlay-Schultz J; Sartorius CA; Cittelly DM
    J Vis Exp; 2016 Nov; (117):. PubMed ID: 27929464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.
    Peng L; Bian XW; Li DK; Xu C; Wang GM; Xia QY; Xiong Q
    Sci Rep; 2015 Aug; 5():13413. PubMed ID: 26292924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the prediction of chemotherapeutic sensitivity of tumors in breast cancer via optimizing the selection of candidate genes.
    Jiang L; Huang L; Kuang Q; Zhang J; Li M; Wen Z; He L
    Comput Biol Chem; 2014 Apr; 49():71-8. PubMed ID: 24440656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating patient-derived colorectal cancer xenografts as preclinical models by comparison with patient clinical data.
    Nunes M; Vrignaud P; Vacher S; Richon S; Lièvre A; Cacheux W; Weiswald LB; Massonnet G; Chateau-Joubert S; Nicolas A; Dib C; Zhang W; Watters J; Bergstrom D; Roman-Roman S; Bièche I; Dangles-Marie V
    Cancer Res; 2015 Apr; 75(8):1560-6. PubMed ID: 25712343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of transcriptome in cancer patient-derived xenografts.
    Li H; Zhu Y; Tang X; Li J; Li Y; Zhong Z; Ding G; Li Y
    PLoS One; 2015; 10(5):e0124780. PubMed ID: 25951608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool.
    Villafranca-Magdalena B; Masferrer-Ferragutcasas C; Lopez-Gil C; Coll-de la Rubia E; Rebull M; Parra G; García Á; Reques A; Cabrera S; Colas E; Gil-Moreno A; Moiola CP
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure.
    Colombo PE; du Manoir S; Orsett B; Bras-Gonçalves R; Lambros MB; MacKay A; Nguyen TT; Boissière F; Pourquier D; Bibeau F; Reis-Filho JS; Theillet C
    Oncotarget; 2015 Sep; 6(29):28327-40. PubMed ID: 26334103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.
    He F; Bandyopadhyay AM; Klesse LJ; Rogojina A; Chun SH; Butler E; Hartshorne T; Holland T; Garcia D; Weldon K; Prado LP; Langevin AM; Grimes AC; Sugalski A; Shah S; Assanasen C; Lai Z; Zou Y; Kurmashev D; Xu L; Xie Y; Chen Y; Wang X; Tomlinson GE; Skapek SX; Houghton PJ; Kurmasheva RT; Zheng S
    Nat Commun; 2023 Nov; 14(1):7600. PubMed ID: 37990009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.